Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
How much coffee is too much? | FDA shares an alert | Many more adults now eligible for statins | Heartflow launches staging tool
Tuesday, July 21, 2026
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

How much coffee is safe for the heart? Doctors explore the benefits and risks of caffeine

Drinking multiple cups of coffee each day may decrease a person's risk of heart disease, heart failure and stroke. However, too much caffeine can still cause issues.

READ MORE >
old elderly couple coffee drink retired love romance man
Share on Twitter Share on Facebook Share on Linkedin

How much coffee is safe for the heart? Doctors explore the benefits and risks of caffeine

Share on Twitter Share on Facebook Share on Linkedin
old elderly couple coffee drink retired love romance man
Drinking multiple cups of coffee each day may decrease a person's risk of heart disease, heart failure and stroke. However, too much caffeine can still cause issues.
READ MORE >

FDA shares warning about certain IV administration sets—heart patients face greatest risk

In most cases, the issue should not cause harm. However, patients with a patent foramen ovale or other right-to-left shunts may face an increased risk of a heart attack or stroke.

READ MORE >
warning safety alert recall healthcare issue
Share on Twitter Share on Facebook Share on Linkedin

FDA shares warning about certain IV administration sets—heart patients face greatest risk

Share on Twitter Share on Facebook Share on Linkedin
warning safety alert recall healthcare issue
In most cases, the issue should not cause harm. However, patients with a patent foramen ovale or other right-to-left shunts may face an increased risk of a heart attack or stroke.
READ MORE >

More than half of U.S. adults now eligible for statin therapy under new cholesterol guidelines

Thanks to updated guidelines published in March, an additional 21.5 million adults between the ages of 30 and 79 are now eligible for statins. Researchers did emphasize that lifestyle changes are another effective way to reduce ASCVD risk. 

READ MORE >
Continuous and high-adherent statin users had lower baseline arterial stiffness which also grew more slowly over time, a new JAMA Network Open study finds.
Share on Twitter Share on Facebook Share on Linkedin

More than half of U.S. adults now eligible for statin therapy under new cholesterol guidelines

Share on Twitter Share on Facebook Share on Linkedin
Continuous and high-adherent statin users had lower baseline arterial stiffness which also grew more slowly over time, a new JAMA Network Open study finds.
Thanks to updated guidelines published in March, an additional 21.5 million adults between the ages of 30 and 79 are now eligible for statins. Researchers did emphasize that lifestyle changes are another effective way to reduce ASCVD risk. 
READ MORE >

Heartflow launches new AI-powered staging tool for coronary plaque assessments

In addition to launching Heartflow Plaque Staging, the company also shared new data at SCCT2026 highlighting the importance of using total plaque volume assessments to diagnose and manage heart patients. 

READ MORE >
Heartflow's Plaque Analysis AI-driven software that automtically assesses the coronary arteries, maps them and adds markers for areas of interest with plaque.
Share on Twitter Share on Facebook Share on Linkedin

Heartflow launches new AI-powered staging tool for coronary plaque assessments

Share on Twitter Share on Facebook Share on Linkedin
Heartflow's Plaque Analysis AI-driven software that automtically assesses the coronary arteries, maps them and adds markers for areas of interest with plaque.
In addition to launching Heartflow Plaque Staging, the company also shared new data at SCCT2026 highlighting the importance of using total plaque volume assessments to diagnose and manage heart patients. 
READ MORE >

Featured Articles

Medical societies take a stand as CMS nears final decision on TAVR proposal

Back in June, CMS proposed significant updates to its current TAVR policies. Three leading healthcare societies have now joined forces to share their own perspective on the potential updates. 

READ MORE >
Heart doctors and surgeons working together. Top cardiology hospitals in the United States.
Share on Twitter Share on Facebook Share on Linkedin

Medical societies take a stand as CMS nears final decision on TAVR proposal

Share on Twitter Share on Facebook Share on Linkedin
Heart doctors and surgeons working together. Top cardiology hospitals in the United States.
Back in June, CMS proposed significant updates to its current TAVR policies. Three leading healthcare societies have now joined forces to share their own perspective on the potential updates. 
READ MORE >

TAVR Patients Are Being Missed: How Teams + AI Are Expediting Care

Sponsored by Medtronic

Listen in to an expert-led discussion of the ALERT Trial and the impact of electronic clinician notifications (ECNs) on the timely treatment of patients with valvular heart disease. While it is estimated that half of patients with symptomatic severe aortic stenosis do not receive timely interventions, the ALERT Trial quantified the impact of clinician alerts in addressing this care gap.

READ MORE >
medtronic_webinar_teaser_2.png
Share on Twitter Share on Facebook Share on Linkedin

TAVR Patients Are Being Missed: How Teams + AI Are Expediting Care

Sponsored by Medtronic

Share on Twitter Share on Facebook Share on Linkedin
medtronic_webinar_teaser_2.png
Listen in to an expert-led discussion of the ALERT Trial and the impact of electronic clinician notifications (ECNs) on the timely treatment of patients with valvular heart disease. While it is estimated that half of patients with symptomatic severe aortic stenosis do not receive timely interventions, the ALERT Trial quantified the impact of clinician alerts in addressing this care gap.
READ MORE >

Wegovy, weight loss and cardiovascular health: A closer look at how semaglutide protects the heart

When patients take semaglutide, you can't necessarily predict the cardiovascular impact by tracking weight loss. A lot of it appears to comes down to the dose. 

READ MORE >
heart data research doctor cardiologist AI
Share on Twitter Share on Facebook Share on Linkedin

Wegovy, weight loss and cardiovascular health: A closer look at how semaglutide protects the heart

Share on Twitter Share on Facebook Share on Linkedin
heart data research doctor cardiologist AI
When patients take semaglutide, you can't necessarily predict the cardiovascular impact by tracking weight loss. A lot of it appears to comes down to the dose. 
READ MORE >

Recall update: FDA now urging clinicians to return vascular device linked to 3 deaths

Cardiologists and vascular surgeons were previously told they could still use the device if necessary. Now, however, the message is that they should return the product to the manufacturer.

READ MORE >
alert FDA recall safety warning
Share on Twitter Share on Facebook Share on Linkedin

Recall update: FDA now urging clinicians to return vascular device linked to 3 deaths

Share on Twitter Share on Facebook Share on Linkedin
alert FDA recall safety warning
Cardiologists and vascular surgeons were previously told they could still use the device if necessary. Now, however, the message is that they should return the product to the manufacturer.
READ MORE >

In Case You Missed It

Americans keep poisoning themselves with semaglutide, other weight loss drugs

These incidents became much more common after the FDA started approving GLP-1 drugs for chronic weight management in 2021. 

READ MORE >
Semaglutide (Wegovy) injector pen. Photo by Dave Fornell
Share on Twitter Share on Facebook Share on Linkedin

Americans keep poisoning themselves with semaglutide, other weight loss drugs

Share on Twitter Share on Facebook Share on Linkedin
Semaglutide (Wegovy) injector pen. Photo by Dave Fornell
These incidents became much more common after the FDA started approving GLP-1 drugs for chronic weight management in 2021. 
READ MORE >

Neurovascular device recalled due to safety concerns

The recall includes a total of nearly 45,000 devices that should be returned to the manufacturer.

READ MORE >
Product Recall
Share on Twitter Share on Facebook Share on Linkedin

Neurovascular device recalled due to safety concerns

Share on Twitter Share on Facebook Share on Linkedin
Product Recall
The recall includes a total of nearly 45,000 devices that should be returned to the manufacturer.
READ MORE >

FDA approves surgical device for high-risk aortic procedures

The AMDS Hybrid Prosthesis was designed to help clinicians treat DeBakey Type 1 dissections complicated by malperfusion. It works as a complement to hemiarch replacement, preserving the native arch and making reinterventions possible if needed. 

READ MORE >
Artivion, an Atlanta-based medical device company, has received a Humanitarian Device Exemption (HDE) from the U.S. Food and Drug Administration (FDA) for its AMDS Hybrid Prosthesis designed to treat DeBakey Type 1 dissections when malperfusion occurs. This HDE ensures select patients can be treated with the device before the FDA makes its final approval decision.
Share on Twitter Share on Facebook Share on Linkedin

FDA approves surgical device for high-risk aortic procedures

Share on Twitter Share on Facebook Share on Linkedin
Artivion, an Atlanta-based medical device company, has received a Humanitarian Device Exemption (HDE) from the U.S. Food and Drug Administration (FDA) for its AMDS Hybrid Prosthesis designed to treat DeBakey Type 1 dissections when malperfusion occurs. This HDE ensures select patients can be treated with the device before the FDA makes its final approval decision.
The AMDS Hybrid Prosthesis was designed to help clinicians treat DeBakey Type 1 dissections complicated by malperfusion. It works as a complement to hemiarch replacement, preserving the native arch and making reinterventions possible if needed. 
READ MORE >

In Other News

Emergency nurses know what it’s like to suffer pangs of moral distress

Like the emergency physicians they work alongside, ER nurses experience moral distress in substantial numbers and multifaceted ways, according to a new study published in the Journal of Clinical Nursing.

READ MORE >
nurse in moral distress
Share on Twitter Share on Facebook Share on Linkedin

Emergency nurses know what it’s like to suffer pangs of moral distress

Share on Twitter Share on Facebook Share on Linkedin
nurse in moral distress
Like the emergency physicians they work alongside, ER nurses experience moral distress in substantial numbers and multifaceted ways, according to a new study published in the Journal of Clinical Nursing.
READ MORE >

MRI helps visualize presence of microplastics on imaging for 1st time

New research suggests that these tiny synthetic pollutants can be visualized on exams, potentially complicating interpretations for radiologists.

READ MORE >
Microplastics can be seen on MRI
Share on Twitter Share on Facebook Share on Linkedin

MRI helps visualize presence of microplastics on imaging for 1st time

Share on Twitter Share on Facebook Share on Linkedin
Microplastics can be seen on MRI
New research suggests that these tiny synthetic pollutants can be visualized on exams, potentially complicating interpretations for radiologists.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Medtech giant makes big move | The world’s top hospitals for heart surgery | New CPT codes | PET vs. SPECT | TAVR tech recalled
AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup